Crescenta Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Crescenta Biosciences's estimated annual revenue is currently $930k per year.
- Crescenta Biosciences's estimated revenue per employee is $155,000
Employee Data
- Crescenta Biosciences has 6 Employees.
- Crescenta Biosciences grew their employee count by 0% last year.
Crescenta Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
Crescenta Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Crescenta Biosciences?
Crescenta Biosciences Inc. is a small molecule drug discovery company focused on developing novel therapeutic approaches for diseases related to fatty acid metabolism. Crescenta’s discovery platform is based on a new concept that allows for the manipulation of biological functions associated with “fatty acid interacting proteins†in such a way to correct metabolic imbalance, thus providing broad therapeutic opportunities. By applying this unique platform, the company has assembled a portfolio of first-in-class drug candidates for the treatment of diseases with major unmet medical needs, particularly those related to metabolism and aging. Crescenta’s goal is to advance its pipeline into clinical development and commercialization.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 7 | 17% | N/A |
#2 | $0.7M | 7 | -12% | N/A |
#3 | $0.7M | 9 | 0% | N/A |
#4 | $1.1M | 11 | -72% | N/A |
#5 | $1M | 11 | 0% | N/A |